NCT00032955View on ClinicalTrials.gov

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Heroin DependenceMorphine DependenceSubstance Withdrawal Syndrome
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (6)

10023

Phoenix House, New York

32801

The Center For Drug-Free Living, Orlando

33781

Operation PAR, Inc., Pinellas Park

43207

Maryhaven, Inc., Columbus

48208

Self Help Addiction Rehabilitation (SHAR), Inc., Detroit

92270

Betty Ford Center, Rancho Mirage

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00032955 - Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1 | Biotech Hunter | Biotech Hunter